Clarke R, Brünner N, Thompson E W, Glanz P, Katz D, Dickson R B, Lippman M E
Vincent T. Lombardi Cancer Research Center, Georgetown University Medical Center, Washington DC 20007.
J Endocrinol. 1989 Jul;122(1):331-40. doi: 10.1677/joe.0.1220331.
Among the processes contributing to the progressive acquisition of the highly malignant phenotype in breast cancer are ovarian-independent growth, antioestrogen resistance and increased metastatic potential. We have previously observed that increased invasiveness and development of ovarian-independent growth occur independently. In an attempt to define the inter-relationships between these processes further, we have compared the phenotypes of ovarian-independent, invasive and antioestrogen-resistant sublines of the ovarian-dependent human breast cancer cell line MCF-7. Cells acquiring ovarian-independent growth can retain sensitivity to anti-oestrogens. One clone of MCF-7 cells selected for stable antioestrogen resistance has become non-tumorigenic but its invasive potential remains unaltered. Thus, acquisition of some characteristics of the progressed phenotype can occur independently. This phenomenon of independent parameters in phenotypic progression could partly explain the considerable intra- and intertumour heterogeneity characteristic of breast tumours.
在乳腺癌中,促成高恶性表型逐步获得的过程包括不依赖卵巢生长、抗雌激素耐药性和转移潜能增加。我们之前观察到侵袭性增加和不依赖卵巢生长的发展是独立发生的。为了进一步确定这些过程之间的相互关系,我们比较了依赖卵巢的人乳腺癌细胞系MCF-7的不依赖卵巢、侵袭性和抗雌激素耐药亚系的表型。获得不依赖卵巢生长的细胞可以保留对抗雌激素的敏感性。一个被选择用于稳定抗雌激素耐药性的MCF-7细胞克隆已变得无致瘤性,但其侵袭潜能仍未改变。因此,进展表型的某些特征的获得可以独立发生。表型进展中参数独立的这一现象可以部分解释乳腺肿瘤显著的肿瘤内和肿瘤间异质性特征。